This review sought to give more information about the types of treadmill training that might be beneficial for patients with Parkinson disease and other neurological disorders engaged in physical rehabilitation programs.
Treadmill training, or TT, is a widely accepted method of gait training in patients who need physical rehabilitation, as it promotes improved walking, balance, and stability, thereby preventing falls and other accidents. However, not much has been known about how it changes the gait of patients with neurological disorders, including Parkinson disease.
TT assists physical therapists with guiding the proper movement and timing of the legs to stimulate a more typical walking pattern without any compensatory movements or adjustments. But it can be difficult for providers to choose the most optimal treatment plan for their patients.
A recent review sought to summarize the latest evidence on the effectiveness of this technique through a systematic review and meta-analysis.
The aim of the report, published in International Journal of Environmental Research and Public Health, was to review and quantify the changes in gait after treadmill interventions in adults with neurological disorders
The review, which initially cast a wide net over numerous neurological conditions, found that the 2 main disorders with the most evidence for TT were PD and stroke rehabilitation.
Researchers searched for keywords in studies published in English in PubMed, CINAHL, Scopus, and Web of Science from January 2000 to December 2021 that were randomized controlled trials of these interventions in adults 55 years and older with a neurological disorder. The studies included spatiotemporal gait characteristics and included stride length, stride time, step length, step width, step time, stance time, swing time, single support time, double support time, or cadence.
After initially retrieving 1792 records, the authors included 32 studies; of those, 19 studies included adults with stroke and 13 studies included adults with PD. Twenty-two of 32 studies examined gait in adults with neurological disorders.
Treadmill interventions included:
Results were analyzed by random plot analysis if heterogeneity was greater than 50% (as denoted by I2); otherwise, researchers used fixed plot analysis. In addition, all analyses used effect sizes and standard errors, and a P < 0.05 threshold was considered statistically significant.
In adults with PD, 2 types of TT had the greatest effect: TT with sensory feedback or TT with bodyweight support. They had the largest impact on cadence, stride length (z = 2.73; I2 = 74.2%), and step length (z = −2.54; I2 = 96.8%), the authors wrote.
In adults with stroke, pure TT and TT with visual cues or incline had the largest effect on step length (z = 2.25; I2 = 74.3%), stride length (z = 6.08), and cadence (z = 6.24; I2 = 11.5%).
Overall, TT interventions had the largest effect on cadence, step length, and stride length among adults with stroke and PD.
The study had some limitations. The researchers were unable to determine the effect of all interventions across a wider range of neurological disorders due to a lack of studies, and the small number of studies limited the ability to detect bias. Larger sample sizes with more neurodiverse populations would be beneficial to examine the effects of using TT, the researchers said.
However, they said their findings will help providers choose the most specific intervention based on the specific needs of patients with either PD or stroke.
Reference
Bishnoi A, Lee R, Hu Y, Mahoney JR, Hernandez ME. Effect of treadmill training interventions on spatiotemporal gait parameters in older adults with neurological disorders: systematic review and meta-analysis of randomized controlled trials. Int J Environ Res Public Health. Published online February 28, 2022. doi:10.3390/ijerph19052824
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy
May 9th 2024A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Read More